Objective: This study aimed to evaluate the effect of optimization of the intravenous infusion workflow in isolation wards for patients with coronavirus disease 2019.
Methods: The infusion management group optimized the intravenous infusion workflow based on Hamer's Process Reengineering Theory and applied it to the treatment of patients with coronavirus disease 2019. The work efficiency, patients' satisfaction and economic indicators before and after optimization were compared.
Results: After the infusion workflow was optimized, average times for preparation drugs and intravenous admixture, and patients' waiting time decreased from 4.84 min, 4.03 min, and 34.33 min to 3.50 min, 2.60 min, and 30.87 min, respectively, patients' satisfaction increased from 66.7% to 93.3%, and the cost of personal protective equipment (PPE) decreased from 46.67 sets and 186.6 CNY per day to 36.17 sets and 144.6 CNY, with statistical significance.
Conclusion: The optimization of the intravenous infusion workflow can effectively decrease the cost of PPE while improving the efficiency of infusion and patients' satisfaction.
Keywords: COVID-19; Drug compounding; Intravenous infusions; Patient satisfaction; Personal protective equipment; Workflow.
© 2020 Chinese Nursing Association. Production and hosting by Elsevier B.V.
Conflict of interest statement
Parenteral product error detection before and after implementation of intravenous workflow management technology.J Oncol Pharm Pract. 2019 Jan;25(1):5-15. doi: 10.1177/1078155217723695. Epub 2017 Aug 4. J Oncol Pharm Pract. 2019. PMID: 28776479
Rationality and irrationality in Ryke Geerd Hamer's system for holistic treatment of metastatic cancer.ScientificWorldJournal. 2005 Jan 28;5:93-102. doi: 10.1100/tsw.2005.16. ScientificWorldJournal. 2005. PMID: 15702221 Free PMC article. Review.
Using lean principles to improve outpatient adult infusion clinic chemotherapy preparation turnaround times.Am J Health Syst Pharm. 2015 Jul 1;72(13):1138-46. doi: 10.2146/ajhp140453. Am J Health Syst Pharm. 2015. PMID: 26092964
Multicenter study to evaluate the benefits of technology-assisted workflow on i.v. room efficiency, costs, and safety.Am J Health Syst Pharm. 2019 Jun 3;76(12):895-901. doi: 10.1093/ajhp/zxz067. Am J Health Syst Pharm. 2019. PMID: 31361850 Clinical Trial.
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499 Review.
- National Health Commission of the People’s Republic of China Latest developments in epidemic control on February 9. http://www.nhc.gov.cn/xcs/yqfkdt/202002/167a0e01b2d24274b03b2ca961107929.shtml, 2020-02-10
- National Health Commission of the People’s Republic of China Diagnosis and treatment protocol for novel coronavirus pneumonia. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml, 2020-02-05 5th Trial Version.
- National Health Commission of the People’s Republic of China Technical guidelines for prevention and control of novel coronavirus infection in medical institutions. http://www.nhc.gov.cn/yzygj/s7659/202001/b91fdb7c304431eb082d67847d27e14.shtml, 2020-01-23 (first ed.
- National Health Commission of the People’s Republic of China Nursing practice standards for intravenous therapy. http://www.nhc.gov.cn/wjw/pjl/201412/806fe9a7171e4cf584c0d40ed093dfa7.shtml, 2014-05-01